Advertisement
Home »

SONIA: No Survival Benefit of First-Line CDK4/6 Inhibition in Metastatic Breast Cancer

Jun 12, 2023

REFERENCES & ADDITIONAL READING

Goetz MP, et al. J Clin Oncol. 2017;35:3638–3646.

Sledge G, et al. J Clin Oncol 2017;35:2875–2884.

Sonke G, et al. Primary outcome of the phase 3 SONIA trial (BOOG 2017-03). Abstract LBA1000. ASCO Annual Meeting 2023, 2–6 June, Chicago.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement